Latest Search
Quote
| Back Zoom + Zoom - | |
|
<Research>CLSA Lifts WUXI APPTEC (02359.HK) TP to $149.3, Keeps Outperform Rating
Recommend 4 Positive 1 Negative 0 |
|
|
|
|
WUXI APPTEC (02359.HK)(603259.SH) will announce its 1Q26 results next Monday (27th), CLSA issued a research report saying. The broker expected earnings momentum to continue accelerating, with an improved business mix and room for valuation re-rating. CLSA forecasted its 1Q26 revenue to grow 20% YoY, including a 25% YoY increase in revenue from continuing operations. High-margin TIDES business and the divestment of low-growth clinical CRO operations are expected to drive adjusted non-IFRS net profit growth of over 35% YoY. Therefore, the broker kept ratings at Outperform for both the H-/ A-shares of WUXI APPTEC, and lifted its target prices from $144.4/ RMB126.7 to $149.3/ RMB130.9, based on an unchanged 20x PE ratio prediction for 2027. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
|
